Target
Prolyl hydroxylase EGLN3
Ligand
BDBM477192
Substrate
n/a
Meas. Tech.
EGLN-1 Activity Assay
IC50
805±21.6 nM
Citation
 You, QZhang, XLei, YHu, TWu, XSun, HGuo, XXu, X Alkynyl pyridine prolyl hydroxylase inhibitor, and preparation method and medical use thereof US Patent  US10889546 Publication Date 1/12/2021 
Target
Name:
Prolyl hydroxylase EGLN3
Synonyms:
EGLN3 | EGLN3_HUMAN | Egl nine homolog 3 (EGLIN3) | Egl nine homolog 3 (EGLN3)
Type:
Protein
Mol. Mass.:
27265.54
Organism:
Homo sapiens (Human)
Description:
Q9H6Z9
Residue:
239
Sequence:
MPLGHIMRLDLEKIALEYIVPCLHEVGFCYLDNFLGEVVGDCVLERVKQLHCTGALRDGQLAGPRAGVSKRHLRGDQITWIGGNEEGCEAISFLLSLIDRLVLYCGSRLGKYYVKERSKAMVACYPGNGTGYVRHVDNPNGDGRCITCIYYLNKNWDAKLHGGILRIFPEGKSFIADVEPIFDRLLFFWSDRRNPHEVQPSYATRYAMTVWYFDAEERAEAKKKFRNLTRKTESALTED
  
Inhibitor
Name:
BDBM477192
Synonyms:
US10889546, Example 2
Type:
Small organic molecule
Emp. Form.:
C13H14N2O4
Mol. Mass.:
262.2613
SMILES:
CC(C)C#Cc1cnc(C(=O)NCC(O)=O)c(O)c1
Structure:
Search PDB for entries with ligand similarity: